BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu JH, Chen N, Guo YH, Guan XN, Wang J, Wang D, Xiu MH. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia. J Psychiatr Res 2021;140:409-15. [PMID: 34144444 DOI: 10.1016/j.jpsychires.2021.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Su L, Xiu M, Guan X, Wu F. Lysophosphatidylethanolamine correlated with cognitive improvements after treatment with olanzapine in drug-naïve first-episode schizophrenia: a prospective cohort study.. [DOI: 10.21203/rs.3.rs-2339101/v1] [Reference Citation Analysis]
2 Jiang Y, Sun X, Hu M, Zhang L, Zhao N, Shen Y, Yu S, Huang J, Li H, Yu W. Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study. Front Psychiatry 2022;13:950602. [DOI: 10.3389/fpsyt.2022.950602] [Reference Citation Analysis]
3 Wang X, Xiu M, Wang K, Su X, Li X, Wu F. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia. Metabolomics 2022;18:50. [PMID: 35819637 DOI: 10.1007/s11306-022-01909-4] [Reference Citation Analysis]
4 Guan X, Xu J, Xiu M, Li X, Liu H, Wu F. Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study. CNS Neurosci Ther 2022. [PMID: 35769008 DOI: 10.1111/cns.13895] [Reference Citation Analysis]
5 Chen C, Nakano T, Hsu L, Chu CY, Huang K. Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression. NDT 2022;Volume 18:645-57. [DOI: 10.2147/ndt.s345046] [Reference Citation Analysis]
6 da Silva Zandonadi F, dos Santos EAF, Marques MS, Sussulini A. Metabolomics: A Powerful Tool to Understand the Schizophrenia Biology. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-97182-3_8] [Reference Citation Analysis]
7 Liu J, Xiu M, Liu H, Wang J, Li X. Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia. Front Pharmacol 2021;12:735196. [PMID: 34603051 DOI: 10.3389/fphar.2021.735196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]